MIRA INFORM REPORT

 

 

Report Date :

13.01.2011

 

IDENTIFICATION DETAILS

 

Name :

POPULAR PHARMACEUTICALS LIMITED

 

 

Registered Office :

House No.25, Road No.2, Dhanmondi R/A, Dhaka-1205

 

 

Country :

Bangladesh

 

 

Date of Incorporation :

08.12.2002

 

 

Com. Reg. No.:

C-47852

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

manufacturing and selling of drugs and medicines

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 25,000.00

Status :

Satisfactory

Payment Behaviour :

No Complaints  

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

Bangladesh

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

COMPANY DETAILS

 

Name

Popular Pharmaceuticals Limited

Address

House No.25, Road No.2, Dhanmondi R/A, Dhaka-1205

Country

Bangladesh

Telephone No

880-2-9675600, 9669301-5

Fax No

880-2-9675633

E-Mail

popular@citechco.net

Website

NIL

Established

December 2002

Company Registration No

C-47852

Registration date

8th December 2002

Legal Status

Private Limited

Issuing Authority

The Register of Joint Stock Companies, Dhaka

Business Type

Manufacturer & Seller

Status

Satisfactory

Payment Behavior

No complaints have been heard regarding payments 

from local suppliers or banks.

 

 

LOCATIONS

 

Head Office

House No.25, Road No.2, Dhanmondi R/A, Dhaka-1205

Telephone No

880-2-9675600, 9669301-5

Fax No

880-2-9675633

E-Mail

popular@citechco.net

Website

NIL

Branch

4 Chittagong

4 Sylhet

4 Bogra

4 Khulna

4 Rangpur

4 Barishal

4 Comilla

4 Cox’s Bazar

4 Jessore

4 Mymensing

4 Faridpur

Factory

164, Tongi Industrial Area, Tongi, Gazipur-1711, Dhaka,

Factory Telephone No

N/A

Factory Fax No

N/A

Warehouse

164, Tongi Industrial Area, Tongi, Gazipur-1711, Dhaka,

 

 

DIRECTORS

 

Name

Dr. Mustafizur Rahman

Designation

Chairman & Managing Director

Nationality

Bangladeshi

 

 

Name

Mr. Nazim Ferdous

Designation

Director

Nationality

Bangladeshi

 

 

SHAREHOLDERS

 

Name

Dr. Mustafizur Rahman

Share Percent

60%

Nationality

Bangladeshi

 

 

Name

Mr. Nazim Ferdous

Share Percent

40%

Nationality

Bangladeshi

 

 

BUSINESS DETAILS

 

Line of Business

Manufacturer & Seller

Items Dealing In

Drugs & Medicines

Terms of Purchase

Local: Cash or Credit

Import: Against L/C

Terms of Sale

Local: Cash or Credit

 

BANKERS

 

Name

Standard Chartered Bank

Branch

Main Branch

Address

Dilkusha Commercial Area, Dhaka         

SWIFT

N/A

 

 

FINANCIAL INFORMATION

 

Year

2009

2008

 

2007

Investment

Tk.27 million

Tk.25 million

Tk.25 million

Turnover

Tk.152.8 million

Tk.152 million

Tk.150 million

Liability

NIL

NIL

NIL

Assets

Tk.48 million

Tk.48 million

Tk.45 million

 

 

CAPITAL STRUCTURE

 

Authorized Capital

Tk.100 million

Paid Up Capital

Tk.500, 000.00

Each Share Value

Tk.100.00

 

 

EXCHANGE RATE

 

Currency

Unit

Bangladeshi Taka (BDT)

 

Great Britain Pound

1

137.1626

U.S Dollar

1

69.4000

European Euro

1

108.8231

 

 

ADVERSE DATA MONITORING

 

Dishonored Checks

No Found

Debt

No Records Found

Litigation

No Records Found

Performance Defaults

No Records Found

Adverse Press Coverage

No Records Found

Money Laundering

No Records Found

 

 

MAXIMUM RECOMMENDED CREDIT

 

Amount

Based On

US$ 25,000.00

90 Days

 

 

GENERAL INFORMATION

 

Employees

365

Office Area (Sq. Ft)

1,250 sq.ft (own)

Factory Area (Sq. Ft)

18,000 sq.ft (own)

Warehouse Area (Sq. Ft)

3,900  sq.ft.(own)

Range of Products

4 Tablets

4 Capsules

4 Suspensions

4 Injections

4 Eye Drops

4 Creams

4 Ointments

4 Animal Drugs

Major Clients 

4 Central Medical Store Depot, Bangladesh Government

4 Bangladesh Army

4 Bangladesh Rifles

4 Police Hospital

4 BIRDEM

4 Chittagong Medical College & Hospital

4 M.A.G. Osmani Medical College & Hospital Sylhet

4 HCDP (Health care Development project)

4 Apollo Hospitals

4 United Hospital

4 Square Hospitals Ltd

4 Labaid Cardiac Hospital

4 Lab Aid Specialized Hospital

Raw Materials From

4  EEC Countries

4  China

4  Korea

4  Singapore

4  Pakistan

4  India

4  Australia

4  Taiwan

Certifications

NIL

Group Name

NIL

Subsidiaries / Affiliates

4 Popular Diagnostic Centre

4 Popular Infusions Limited

Member

4 Bangladesh Association of Pharmaceuticals, Dhaka

4 Dhaka Chamber of Commerce & Industries, Dhaka

 

 

COMMENTS

 

The subject is a private limited company who is engaged in manufacturing and selling of drugs and medicines. The company’s factory is most modern and the quality of their products is of international standard. Their products are popular and sold all over the country.

 

The directors are well conversant in their line of trade and they are also experienced businessman. They are financially solvent and good at their business commitments, it is reported.

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.45.16

UK Pound

1

Rs.70.64

Euro

1

Rs.58.68

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.